Jeanne M Manson, Ph. D. , Mary D Sammel, Ellen W Freeman, Ph. D

Slides:



Advertisements
Similar presentations
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Advertisements

Rebecca Greene, B. A. , Pamela Stratton, M. D. , Sean D. Cleary, Ph. D
Carlos Morán, M. D. , Eric Knochenhauer, M. D. , Larry R Boots, Ph. D
Philip M. Sarrel, M. D. , Shannon D. Sullivan, M. D. , Ph. D
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Female exposure to phenols and phthalates and time to pregnancy: the Maternal-Infant Research on Environmental Chemicals (MIREC) Study  Maria P. Vélez,
Cervical neoplasia–related factors and decreased prevalence of uterine fibroids among a cohort of African American women  Kristen R. Moore, M.S.P.H.,
Age at menarche: a predictor of diminished ovarian function?
Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women's Health Across the Nation  Rebecca C.
Evaluation of basal estradiol levels in assisted reproductive technology cycles2  John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,
Who requests their sperm donor's identity
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Infertility evaluation and treatment among women in the United States
Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States  Jennifer.
Ramifications of adolescent menstrual cycles ≥42 days in young adults
Karen Purcell, M. D. , Ph. D. , Michael Schembri, M. S. , Linda M
Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J
Urinary reproductive hormone level differences between African American and Caucasian women of reproductive age  Susan R Reutman, Ph.D., Grace Kawas LeMasters,
A model for predicting age at menopause in white women
Robot-assisted laparoscopy for infertility treatment: current views
Association of the −243 A→G polymorphism of the glutamate decarboxylase 2 gene with obesity in girls with premature pubarche  Selma Feldman Witchel, M.D.,
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
The prevalence of eating disorders in infertile women
Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females  Josephine Z. Kasa-Vubu, M.D., Vandana.
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women  Raymond W Ke,
A comparison of blood spot vs
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Ellen W. Freeman, Ph. D. , Clarisa R. Gracia, M. D. , Mary D
High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage  Luciano G Nardo,
Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted.
Assisted reproductive technology in the United States: 1999 results generated from the American Society for reproductive medicine/society for assisted.
Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos 
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity  Katherine.
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle  Nancy J. Kenney,
Success of intrauterine insemination in women aged 40–42 years
Links between age at menarche, antral follicle count, and body mass index in African American and European American women  Sonya M. Schuh, Ph.D., Julia.
Jennifer Lucero, M. D. , Bernard L Harlow, Ph. D
A prospective cohort study of physical activity and time to pregnancy
Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors  José Bellver, M.D., Antonio.
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis  Rina Agrawal,
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis  Dorte.
Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.
Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation  Allison Styne-Gross, M.D., Karen.
A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro.
Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D
Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women.
Effectiveness of highly purified human menopausal gonadotropin vs
Rebecca Greene, B. A. , Pamela Stratton, M. D. , Sean D. Cleary, Ph. D
Genome-wide linkage analysis to age at natural menopause in a community-based sample: the Framingham Heart Study  Joanne M. Murabito, M.D. Sc.M., Qiong.
Angelo Cagnacci, M. D. , Ph. D. , Renata Zanin, M. D
The menopausal transition
Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence 
A critique of the Women’s Health Initiative hormone therapy study
Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles  Lauren Johnson, M.D., M.S.C.E., Mary D. Sammel,
Economic evaluation of highly purified menotropin compared with recombinant follicle- stimulating hormone in assisted reproduction  Adam Lloyd, M.Phil.,
Association of endometriosis with body size and figure
Current evaluation of amenorrhea
Touraj Mahmoudi, M. Sc. , Hamid Gourabi, Ph. D. , Mahnaz Ashrafi, M. D
Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility  H.-H.
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
Hormones, mood, sexuality, and the menopausal transition
Soluble HLA-G in the peritoneal fluid of women with endometriosis
Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest  Inka Wiegratz, Ph.D.,
The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition  Siobán D. Harlow, Ph.D., Ellen S. Mitchell, Ph.D.,
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome  Robert P. Kauffman,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Presentation transcript:

Racial differences in sex hormone levels in women approaching the transition to menopause  Jeanne M Manson, Ph.D., Mary D Sammel, Ellen W Freeman, Ph.D., Jean A Grisso  Fertility and Sterility  Volume 75, Issue 2, Pages 297-304 (February 2001) DOI: 10.1016/S0015-0282(00)01723-4

Figure 1 Schedule of Study Assessments. Current evaluation is of cycles 1 to 4. BD = Blood draw for hormone measurements. Psychological and physical symptoms were measured during the first cycle of each assessment period. Manson. Hormones approaching transition to menopause. Fertil Steril 2001. Fertility and Sterility 2001 75, 297-304DOI: (10.1016/S0015-0282(00)01723-4)

Figure 2 Estradiol levels by age at enrollment and body mass index. ▵ Caucasians = 1. □ African Americans = 2. Manson. Hormones approaching transition to menopause. Fertil Steril 2001. Fertility and Sterility 2001 75, 297-304DOI: (10.1016/S0015-0282(00)01723-4)

Figure 3 DHEAS levels by age at enrollment and body mass index. ▵ Caucasians = 1. □ African Americans = 2. Manson. Hormones approaching transition to menopause. Fertil Steril 2001. Fertility and Sterility 2001 75, 297-304DOI: (10.1016/S0015-0282(00)01723-4)